Sanofi (SNYNF) Amortization (2009 - 2026)

Sanofi has disclosed Amortization across 18 years of filings, most recently posting $2.7 billion for Q1 2026.

• Amortization for Q1 2026 came in at $2.7 billion, up 13.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $25.1 billion (up 42.06% YoY), and the FY2025 annual result was $83.5 billion, changed 0.33% from the prior year.
• Amortization came in at $2.7 billion for Q1 2026 at Sanofi, down from $11.1 billion in the prior quarter.
• In the past five years, Amortization ranged from a high of $28.7 billion in Q2 2024 to a low of $2.1 billion in Q1 2024.
• The 5-year median for Amortization is $6.4 billion (2024), against an average of $10.2 billion.
• Across the five-year window, Amortization soared 347.05% in 2023 and fell 28.45% in 2024, its largest moves.
• Sanofi's Amortization stood at $2.2 billion in 2022, then soared by 347.05% to $9.8 billion in 2023, then fell by 2.48% to $9.5 billion in 2024, then gained by 16.79% to $11.1 billion in 2025, then plunged by 76.17% to $2.7 billion in 2026.
• The last three Amortization figures came in at $2.7 billion (Q1 2026), $11.1 billion (Q4 2025), and $9.0 billion (Q3 2025), per Business Quant data.